| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director | Chief Financial Officer
2 companies
Robert J Michel is Chief Financial Officer at DXR and has filed Form 4s across 2 companies. From May 2017 to June 2026, the filings on record show 14 open-market purchases and 0 sales. Robert J Michel's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $349K at current prices.
Historically, Robert J Michel's trades have earned a middling insider score of 62/100 across 11 rated trades. Over a 12-month horizon, 55.6% of those trades were profitable, with an average 12-month return of +6.1%.
The biggest single holding is DXR (~$294K) as Chief Financial Officer. Net of sales, the DXR filings show accumulation of 17,050 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19, 2021 | DXR Daxor Corp | Chief Financial Officer | Buy | 1,000 | $10.25 | $10,250.00 | +30.8% | -9.2% | +8.9% | |
| Mar 22, 2019 | DXR Daxor Corp | Chief Financial Officer | Buy | 750 | $13.02 | $9,765.00 | +30.0% | - | - | |
| Nov 28, 2018 | BKYI Bio Key International Inc | Director | Buy | 5,000 | $1.27 | $6,350.00 | +76.1% | - | - | |
| Nov 7, 2018 | DXR Daxor Corp | Chief Financial Officer | Buy | 2,500 | $7.42 | $18,550.00 | New | - | - |